SecBot SecBot
144 ·Filed Sep 25, 2026

DFTX

Definium Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001950047-26-009817
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine insider intent-to-sell notice with a small share count. Monitor for actual sale execution on Form 4, but no material impact is expected from this filing alone.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled: T+20d ⚠ clustered
DFTX ▼ -7.11% at T+20d
NEUTRAL call -7.11% · α vs SPY -7.08% · entry $38.41 → $35.68
Next anchor: T+60d in 7w
Latest observation: T+21 +3.85% FF3 residual α
Entry = T+0 close
Sep 25, 2026
via day close
T+1d
-0.52%
call -0.52% · α -0.34%
$38.21
settled 5w ago
T+5d
-5.68%
call -5.68% · α -6.88%
$36.23
settled 28d ago
T+20d
-7.11%
call -7.11% · α -7.08%
$35.68
settled 7d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Brandi Roberts, an officer of Definium Therapeutics, filed a Form 144 on September 25, 2026, indicating intent to sell 3,377 shares of common stock with an estimated aggregate market value of approximately $124,037. The shares were acquired via restricted stock vesting under a registered plan. This is a relatively small sale relative to the company's market cap and appears to be a routine insider transaction.

Key Facts

  • Filer: Brandi Roberts, an officer of Definium Therapeutics.
  • Proposed sale: 3,377 shares of common stock.
  • Estimated aggregate market value: ~$124,037.
  • Shares acquired via restricted stock vesting under a registered plan on June 25, 2026.
  • Filing date: September 25, 2026.
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.

Financial Impact

Proposed sale of 3,377 shares valued at ~$124,037, small relative to the company's market cap.

dilution

Risk Factors

  • Insider selling could signal lack of confidence if followed by larger sales.
  • Form 144 is only an intent to sell; the sale may not occur.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-009817
Document: 0001950047-26-009817-index.html0001950047-26-009817
Document: 0001950047-26-009817.txt0001950047-26-009817
13 reports for DFTX
Performance horizon
71% Hit rate @ T+5 5 of 7 directional calls Went positive at some point 5 of 7 best @ T+60▲ +13.35%Jun 24, 2026
Filters
Rows
Reports for DFTX, sortable and filterable
TypeNow
Sep 29, 2026
4w ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $35.09▲ +7.80%▲ +9.72%$37.96 (+0.26%)
Sep 25, 2026
4w ago
144
NEUTRAL ★ 2/10
$38.41 $36.23▼ −5.68%▼ −6.88%$37.96 (−1.17%)
Sep 25, 2026
4w ago
144
NEUTRAL ★ 2/10
$38.41 $36.23▼ −5.68%▼ −6.88%$37.96 (−1.17%)
Sep 25, 2026
4w ago
144
NEUTRAL ★ 3/10
$38.41 $36.23▼ −5.68%▼ −6.88%$37.96 (−1.17%)
Sep 14, 2026
6w ago
8-K
BULLISH ★ 8/10
$40.25 $39.28▼ −2.41%▼ −2.52%$37.96 (−5.69%)
Aug 12, 2026
11w ago
8-K
BULLISH ★ 7/10
$42.79 $45.82▲ +7.08%▲ +7.53%$37.96 (−11.29%)
Aug 9, 2026
11w ago
Institutional Cluster
BULLISH ★ 5/10
$45.15 $45.26▲ +0.24%▲ +0.29%$37.96 (−15.92%)
Jun 25, 2026
18w ago
144
NEUTRAL ★ 3/10
$44.95 $44.19▼ −1.69%▼ −3.86%$37.96 (−15.55%)
Jun 25, 2026
18w ago
144
NEUTRAL ★ 2/10
$44.95 $44.19▼ −1.69%▼ −3.86%$37.96 (−15.55%)
Jun 24, 2026
18w ago
8-K
BEARISH ★ 6/10
$44.79 $43.40▲ +3.10%▲ +4.66%$37.96 (+15.25%)
Showing 10 of 13

US Market Status

Market Closed · Opens in 2h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 25, 2026